Skip to main content
. 2024 Jul 25;37:12969. doi: 10.3389/ti.2024.12969
ANCA Anti-neutrophil cytoplasmic antibody
APOL1 Apolipoprotein L1
CAAR Chimeric autoantibody receptor
c-mip c-maf inducing protein
CMV Cytomegalovirus
CNI Calcineurin inhibitor
CTLA4 Cytotoxic T-lymphocyte antigen 4
DSA Donor specific antibody
EBV Ebstein-Barr virus
ESKD End stage kidney disease
FSGS Focal segmental glomerulosclerosis
GBM Glomerular basement membrane
HHV-8 Human herpesvirus-8
HLA Human leukocyte antigen
ICI Immune checkpoint inhibitor
IgA Immunoglobulin A
IL Interleukin
KSHV Kaposi’s sarcoma herpesvirus
MCD Minimal change disease
MHC Major histocompatibility complex
MN Membranous nephropathy
MPGN Membranoproliferative glomerulonephritis
mTOR Mammalian target of rapamycin
NELL-1 Neural epidermal growth factor-like 1
NK Natural killer
PCDH7 Protocadherin 7
PD-1 Programmed cell death 1
PLA2R Phospholipase A2 receptor
sHLA-G Soluble HLA-G
TGF-β Transforming growth factor β
THSD7A Thrombospondin type-1 domain-containing 7A
TMA Thrombotic microangiopathy
TPE Therapeutic plasma exchange
VEGF Vascular endothelial growth factor